Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01510392 · ClinicalTrials.gov registry record
CEI Van Outreach Screening Study
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 118
- Enrollment target
NCT01510392 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 118 participants.
The verdict
NCT01510392 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 118 participants
- Enrollment target
Study Summary
The primary goal of the trial is to show that optical coherence tomography (OCT) technology can be used to effectively screen for diseases of the eye including glaucoma, macular diseases and keratoconus. Glaucoma is a disease that causes permanent vision loss and is usually accompanied by increased eye pressure. Macular diseases affect sharp, central vision. Keratoconus is a disease that affects the cornea (clear surface covering the colored part of the eye).
Interventions
- DEVICE OCT imaging, the FDA Cleared iVue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2012-01 |
| Est. Completion | 2017-02-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01510392
The ClinicalTrials.gov registry entry for NCT01510392 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which OCT imaging, the FDA Cleared iVue is the first listed.
NCT01510392 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01510392 about?
NCT01510392 is a clinical study titled "CEI Van Outreach Screening Study". The primary goal of the trial is to show that optical coherence tomography (OCT) technology can be used to effectively screen for diseases of the eye including glaucoma, macular diseases and keratoconus. Glaucoma is a disease that causes permanent vision loss and is usually accompanied by increased ...
What is the current status of trial NCT01510392?
This trial is currently completed. The enrollment target is 118 participants. The study started on 2012-01. Estimated completion is 2017-02-02.
What interventions are being tested in trial NCT01510392?
The interventions under investigation include: OCT imaging, the FDA Cleared iVue (DEVICE).
Who is sponsoring clinical trial NCT01510392?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.